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Abstract
Psychosocial adversity in childhood (e.g. abuse) and low socioeconomic position (SEP) can have significant lasting effects on
social and health outcomes. DNA methylation-based biomarkers are highly correlated with chronological age; departures of
methylation-predicted age from chronological age can be used to define a measure of age acceleration, which may represent
a potential biological mechanism linking environmental exposures to later health outcomes. Using data from two cohorts of
women Avon Longitudinal Study of Parents and Children, (ALSPAC), N¼989 and MRC National Survey of Health and
Development, NSHD, N¼773), we assessed associations of SEP, psychosocial adversity in childhood (parental physical or
mental illness or death, parental separation, parental absence, sub-optimal maternal bonding, sexual, emotional and physi-
cal abuse and neglect) and a cumulative score of these psychosocial adversity measures, with DNA methylation age accelera-
tion in adulthood (measured in peripheral blood at mean chronological ages 29 and 47 in ALSPAC and buccal cells at age 53 in
NSHD). Sexual abuse was strongly associated with age acceleration in ALSPAC (sexual abuse data were not available in
NSHD), e.g. at the 47-year time point sexual abuse associated with a 3.41 years higher DNA methylation age (95% CI 1.53 to
5.29) after adjusting for childhood and adulthood SEP. No associations were observed between low SEP, any other psychoso-
cial adversity measure or the cumulative psychosocial adversity score and age acceleration. DNA methylation age accelera-
tion is associated with sexual abuse, suggesting a potential mechanism linking sexual abuse with adverse outcomes.
Replication studies with larger sample sizes are warranted.
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Introduction
Psychosocial adversity in childhood (e.g. abuse, neglect, or paren-
tal separation) and low socioeconomic position (SEP) can have
significant and lasting effects on social, psychological, and health
outcomes in later life (1–6). Identifying strategies to reduce or
potentially eliminate the harmful effects of early adversity is cru-
cial for combating inequalities. While there is a large body of evi-
dence documenting the long-term consequences of early life
psychosocial adversity and SEP, the pathways and mechanisms
through which they occur remain unclear. The potential of epige-
netics as a set of gene regulatory mechanisms linking environ-
mental exposures to later outcomes is gaining prominence (7,8).
DNA methylation, the addition of methyl groups to nucleotide
bases, is the epigenetic modification most widely analysed in
population studies. Animal models have identified associations
between early life stress and altered methylation patterns (9–12);
many of these were confirmed in human studies of low SEP(13)
and childhood abuse (14–16).
A recent development within epigenetic research is the ‘epi-
genetic clock’; a set of DNA methylation markers that can be
used to estimate chronological age with high accuracy (R¼ 0.96)
(17). These estimates are referred to as ‘epigenetic age’ and it is
said that epigenetic age is accelerated when it is higher than
true chronological age (17). One hypothesis is that accelerated
epigenetic age indicates accelerated biological aging, potentially
attributable to the influence of environmental factors such as
stress, diet or disease. Obesity, for example, is known not only
to accelerate processes associated with aging (18) but also to
accelerate sexual maturation in females (19,20). Not surpris-
ingly, obesity was recently linked to accelerated epigenetic age
in the liver (21). Accelerated epigenetic age is associated with
lower lung function, cognitive function and physical capability
(22), and with increased mortality, with a 5-year difference
between chronological and methylation age associated with a
21% higher risk of mortality (23).
In this study, we investigate whether SEP and psychosocial
adversity are associated with epigenetic age acceleration, moti-
vated by the idea that this may reflect a biological mechanism
linking psychosocial adversity and low SEP in childhood with
long-term adverse health outcomes. We used data from two
large prospective cohort studies to investigate the associations
between psychosocial adversity and SEP in childhood and epi-
genetic age acceleration from peripheral tissues collected in
adulthood. Given the known co-occurrence of multiple forms of
psychosocial adversity and the potential presence of cumula-
tive effects on health (24–27), we analyse a cumulative score of
psychosocial adversity in addition to exploring whether differ-
ent types of psychosocial adversity have differing associations
with epigenetic age acceleration.
Results
Data were available for 989 women in the ALSPAC cohort and
773 women in NSHD (Supplementary Material, Tables S1 and
S10). The mean age at DNA methylation assessment was 28.7
(SD¼ 5.54) years for the first time point in ALSPAC, 47.3
(SD¼ 4.42) years for the second time point in ALSPAC, and 53.4
(SD¼ 0.16) years in NSHD. The mean derived epigenetic age was
similar to mean chronological age for both time points in
ALSPAC, but in NSHD epigenetic age was on average 9 years
younger than chronological age (Table 1). We found lower than
previously reported Pearson correlation coefficients between
chronological age and epigenetic age (r¼0.45, 0.50 and 0.12 for
the 29-year ALSPAC, 47-year ALSPAC and NSHD, respectively).
Epigenetic age acceleration (the residuals of a regression
between chronological age and epigenetic age) was on average
close to zero in all samples, with the non-zero mean at the
47-year ALSPAC timepoint being due to the multiple imputa-
tion. The correlation between epigenetic age acceleration at the
two ALSPAC time points was 0.27.
Table 2 shows the prevalence of low SEP, each type of psy-
chosocial adversity, and each category of the cumulative psy-
chosocial adversity score. The highest prevalence was for
maltreatment in ALSPAC and parental physical illness in NSHD.
Prevalence was higher in ALSPAC for parental mental illness,
parental physical illness, parental separated, parental absence
and maltreatment than in NSHD. Child illness, sub-optimal
maternal bonding and death of a parent were more common in
NSHD than in ALSPAC. Prevalence was slightly higher for man-
ual SEP in childhood within NSHD, with higher levels of cumula-
tive adversity observed in ALSPAC. Associations between
different adverse experiences varied (e.g. 5% for parental
absence from household and child physical illness, and 46% for
parental mental illness and sub-optimal maternal bonding in
ALSPAC) (Supplementary Material, Tables S11 and S13). For
those who experienced sexual abuse, 6% also experienced phys-
ical neglect, and 79% also experienced emotional neglect
(Supplementary Material, Table S12).
There was no evidence for associations of cumulative psy-
chosocial adversity or childhood SEP with age acceleration in
either cohort (Table 3). Results were similar for complete case
analysis (Supplementary Material, Table S14) and for the
extended cumulative psychosocial adversity score in ALSPAC
(Supplementary Material, Table S15).
Sexual abuse was strongly associated with age acceleration
at both ALSPAC time points, which remained after adjustments
for childhood and adulthood SEP, e.g. sexual abuse was associ-
ated with a 3.41 years higher DNA methylation age acceleration
(95% CI 1.53 to 5.29) at the 47-year time point, after adjusting
for both childhood and adulthood SEP. Sexual abuse
associations were similar in complete case, non-imputed data
(Supplementary Material, Table S17; Figs S1 and S2). Parental
mental illness was associated with negative age acceleration in
the ALSPAC 29-year methylation data, and the association
remained with adjustment for childhood and adulthood socioe-
conomic status, but no evidence of association was seen in the
older ALSPAC sample or in NSHD. There was no evidence of
association between any of the other individual measures of
psychosocial adversity and methylation age acceleration
(Table 4 for unadjusted results, Supplementary Material, Table
S16 for adjusted results). There was no evidence that the associ-
ation between the cumulative psychosocial adversity score and
methylation age acceleration differed according to adult SEP
(Table 5).
Table 1. Characteristics of participants included in the analysis
Measures of age (years) ALSPAC NSHD
29-year data 49-year data
(n¼ 989) (n¼ 989) (n¼ 773)
Mean (SD)
Chronological age 28.65 (5.54) 47.34 (4.42) 53.44 (0.16)
Epigenetic age 30.05 (6.74) 44.66 (6.86) 42.81 (5.72)
Age acceleration 0.04 (5.19) 0.28 (5.51) 0.02 (5.68)
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Discussion
In this study, sexual abuse was associated with DNA methyla-
tion age acceleration of approximately 3 years in analysis of
data from the mothers of the ALSPAC study. This association
was robust to adjustment for both childhood and adulthood
SEP. We did not identify associations of low SEP, a cumulative
score of total psychosocial adversity, or other individual types
of psychosocial adversity with DNA methylation age accelera-
tion. Parental mental illness was associated with negative DNA
methylation age acceleration in one time point in the ALSPAC
mothers, but this association did not replicate in the older time
point in the ALSPAC mothers, nor in NSHD.
The association between sexual abuse and DNA methylation
age acceleration is intriguing given the known associations
between sexual abuse and a wide range of adverse outcomes
(28), and the previously reported association between
higher DNA methylation age and premature mortality (23).
Unfortunately, sexual abuse was not measured in the NSHD
cohort, so we were unable to replicate this finding to determine
whether it is likely due to chance. A recent study of high risk
inner-city youth (n¼ 124, 68% of whom reported at least one
form of maltreatment) identified differentially methylated
probes for physical abuse (34 probes), sexual abuse (7 probes)
and physical neglect (118 probes). No differentially methylated
probes were identified for emotional abuse or neglect (29).
Several other studies have also examined associations between
child abuse and DNA methylation, but most use composite
measures of abuse or maltreatment and are therefore unable to
assess whether methylation changes differ for sexual versus
physical or emotional abuse (15,30–33). This is important as,
although there is co-occurrence between different types of
adversity, we see here that not everyone who has experienced
sexual abuse has also experienced other forms of adversity. In
our analysis, a broader measure of child maltreatment and
measures of physical and emotional cruelty were not associated
with DNA methylation age. To our knowledge, no other studies
have examined associations of sexual abuse or other forms of
psychosocial adversity with DNA methylation age acceleration.
The reasons for lack of associations with methylation age
acceleration for SEP and measures of psychosocial adversity
other than sexual abuse are unclear. It is possible that our a pri-
ori hypothesis that adversity would manifest in higher age
acceleration was incorrect, and that methylation as a biomarker
of biological age does not reflect the influences of early life
adversity, other than for sexual abuse (although this finding
requires replication as discussed above). That said, it is possible
that other changes to DNA methylation, not considered in this
study, may be more relevant biological markers for psychosocial
adversity, since associations between various forms of adversity
and epigenetic changes at multiple sites on the genome have
been identified in previous studies (16). Alternatively, adversity
during specific developmental time periods could affect methyl-
ation age; only an accumulation of adversity from conception to
age 17 years was measured here. Another possible explanation
for our findings is that individuals who experience adverse
childhood experiences but remain active participants of a
cohort study (i.e. those people who are exposed to low SEP or
psychosocial adversity but remain engaged in the cohorts) are
more resilient than average and perhaps possess characteristics
that protect them from the adverse consequences of their early
life experiences. Associations may also only exist in the short-
term and not persist (34) given that, in our study, there was a
long time lag between the exposures (childhood) and the meas-
ures of methylation age acceleration (29, 47 and 53 years). This
has also been documented in a previous study which shows
non-persistence of methylation differences at some loci from
birth to adolescence (34).
Strengths and limitations
A key strength of this study is the use of two cohort studies
with comparable data on childhood adversity. We considered a
large number of types of psychosocial adversity, analysing
them separately in case of distinct associations with methyla-
tion age acceleration, and jointly to account for their known
co-occurrence and cumulative effects on long-term outcomes
(24–27). We used the Horvath algorithm for estimating methyla-
tion age (17) and although other procedures are available(35),
the Horvath method was validated using a range of biological
samples, which is appropriate given we had blood samples in
ALSPAC and buccal samples in NSHD (36).
We used a categorical cumulative score for all analyses as
there was evidence of non-linearity for the 47-year ALSPAC
sample (P¼ 0.03) using a likelihood ratio test comparing models
including the score as a continuous or a categorical variable. We
may not have had sufficient statistical power to detect small
Table 2. Prevalence of low SEP and psychosocial adversity in
childhood
ALSPAC NSHD
(n¼ 989) (n¼ 773)
% Prevalence P-value for
differencea
Manual SEP in childhood 47.7 56.7 <0.001
Psychosocial adversity before 17 years:
Parent physically ill 28.7 27.2 0.47
Parent absent 16.2 2.3 <0.001
Child illness 5.3 14.1 <0.001
Parent mentally ill 32.5 1.8 <0.001
Sub-optimal maternal bonding 16.5 20.7 0.02
Parents separated 13.3 5.8 <0.001
Parent died 5.1 7.1 0.07
Child maltreatment 23.0 7.2 <0.001
Cumulative psychosocial adversity score
0 33.7 40.0 <0.001
1 28.3 39.2
2 17.0 16.2
3þ 21.1 4.5
Items in maltreatment variable in ALSPAC
Physical cruelty 3.5 —
Emotional cruelty 8.4 —
Physical neglect 1.5 —
Emotional neglect 20.2 —
Sexual abuse 3.8 —
Additional items measured only in ALSPAC
Adopted 2.4 —
Spent time in care 1.2 —
Poor family function 13.6 —
Cumulative psychosocial adversity score including additional items meas-
ured only in ALSPAC
0 32.4 —
1 26.9 —
2 15.8 —
3þ 24.9 —
aUsing a chi-squared test.
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associations due to the sample size; post hoc power calculations
suggest we had power to detect a difference of 1 year of age
acceleration in ALSPAC and just over 1 year of age acceleration
in NSHD. Furthermore, the prevalence of some types of adver-
sity was low, which may have also reduced our power to detect
associations. That said, the results were similar for the categori-
cal cumulative score (which did not have low prevalence) and
for ALSPAC and NSHD. It should be noted that due to the sample
origin in NSHD, we could not adjust for cell count, as done so in
ALSPAC. However, adjusting for cell counts in ALSPAC did not
alter the results.
The summed score method of assessing cumulative psycho-
social adversity assumes that each adverse experience has the
same direction and magnitude of association with epigenetic
age, which may be an unrealistic assumption (37). Other data-
driven approaches are available that weight adverse exposures
based the correlations between them (e.g. factor analysis), and
this was our a priori preferred analysis strategy. However, model
fit was very poor in NSHD, potentially due to the lower associa-
tions between the adversity measures in this cohort, precluding
the use of these models. Reassuringly, however, analysis in
ALSPAC demonstrated that results were unchanged when using
the factor analysis or simple sum score approaches.
We observed a large mean difference between chronological
and methylation age in NSHD; this may be due to the methyla-
tion data being derived from buccal samples in this cohort, but
should not bias our results as the distribution of age acceleration
should be unaffected. In contrast to the original study by Horvath
Table 3. Associations of childhood SEP and cumulative psychosocial adversity with methylation age acceleration
ALSPAC age 29y ALSPAC age 47y NSHD age 53y
(n¼ 989) (n¼ 989) (n¼ 773)
Mean difference in methylation age acceleration (years) (95% CI)
Psychosocial adversity score
Unadjusted
0 (ref)
1 0.04 (0.84, 0.93) 0.61 (0.31, 1.54) 0.56 (0.37, 1.48)
2 0.84 (1.89, 0.22) 0.41 (0.70, 1.51) 0.61 (1.82, 0.61)
3 0.27 (1.20, 0.67) 0.03 (0.96, 1.03) 1.38 (3.50, 0.74)
Adjusted for childhood SEP
0 (ref)
1 0.04 (0.85, 0.92) 0.61 (0.31, 1.53) 0.55 (0.38, 1.48)
2 0.84 (1.90, 0.22) 0.40 (0.70, 1.50) 0.61 (1.82, 0.61)
3 0.25 (1.19, 0.69) 0.05(0.95, 1.05) 1.39 (3.51, 0.73)
Additionally adjusted for adulthood SEP
0 (ref)
1 0.03 (0.85, 0.92) 0.59 (0.34, 1.51) 0.58 (0.35, 1.50)
2 0.84 (1.90, 0.22) 0.40 (0.70, 1.50) 0.54 (1.75, 0.68)
3 0.25 (1.19, 0.69) 0.07 (0.93, 0.61) 1.30 (3.42, 0.82)
Childhood socioeconomic position (manual versus non-manual)
Unadjusted 0.26 (0.98, 0.46) 0.31 (1.08, 0.46) 0.13 (0.69, 0.95)
Adjusted for cumulative psychosocial adversity 0.26 (0.98, 0.46) 0.29 (1.06, 0.48) 0.12 (0.70, 0.94)
Additionally adjusted for adult SEP 0.24 (0.98, 0.50) 0.18 (0.97, 0.61) 0.30 (0.54, 1.14)
Table 4. Associations between all forms of psychosocial adversity and methylation age acceleration (unadjusted)
ALSPAC 29-year data ALSPAC 47-year data NSHD at 53 years
(n¼989) (n¼ 989) (n¼ 773)
Mean difference in methylation age acceleration (years) (95% CI)
Parental physical illness 0.37 (1.11, 0.38) 0.11 (0.68, 0.90) 0.61 (1.51, 0.29)
Parental absence 0.22 (0.68, 1.13) 0.04 (0.99, 0.90) 0.76 (1.90, 3.42)
Childhood physical illness 0.71 (2.27, 0.84) 0.09 (1.52, 1.69) 0.07 (1.09, 1.22)
Parental mental illness 0.79 (1.56, 0.03) 0.03 (0.79, 0.74) 2.41 (0.59, 5.42)
Sub-optimal maternal bonding 0.10 (1.09, 0.88) 0.13 (1.10, 0.84) 0.04 (1.08, 1.01)
Parental divorce/separation 0.28 (0.71, 1.27) 0.56 (1.60, 0.47) 0.97 (2.68, 0.74)
Parental death 0.72 (0.87, 2.30) 0.29 (1.33, 1.91) 0.26 (1.82, 1.30)
Child maltreatment 0.05 (0.76, 0.86) 0.12 (0.76, 1.01) 1.26 (2.93, 0.41)
Adoption 0.17 (2.00, 2.34) 0.85 (3.13, 1.43) n/a
Physical cruelty 0.84 (1.04, 2.72) 0.15 (1.81, 2.12) n/a
Emotional cruelty 0.28 (1.52, 0.95) 0.32 (1.61, 0.96) n/a
Physical neglect 0.83 (3.60, 1.95) 2.06 (5.40, 1.27) n/a
Emotional neglect 0.28 (0.57, 1.13) 0.12 (1.01, 0.77) n/a
Spent time in care 0.35 (3.44, 2.75) 1.43 (4.72, 1.86) n/a
Poor family function 0.91 (0.13, 1.95) 0.48 (1.71, 0.74) n/a
Sexual abuse 2.74 (0.93, 4.56) 3.34 (1.47, 5.22) n/a
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et al used to develop the measure of epigenetic age (17), we found
low Pearson’s correlation coefficients between chronological age
and predicted/epigenetic age. As demonstrated in other cohorts
(22,23), this likely reflects the low variability of chronological age
amongst our participants, as high correlations (such as r¼ 0.96
which was observed in the aforementioned study) have been
observed in data sets comprised of subjects with a wide range of
chronological ages. Adversity measures were self-reported in
adulthood in the ALSPAC study, and in the NSHD study were
primarily parent-reported during childhood. There is no gold
standard method for measuring psychosocial adversity, and
parent- and self-reports may lead to underestimation of differing
types of adversity. It should also be noted that maltreatment was
generated from multiple questions about different types of
adverse experiences in ALSPAC. It is possible that pregnancy
induces changes to epigenetic age that could have affected our
results for the first time point in the ALSPAC mothers, however, it
is reassuring that similar results were observed with all outcomes
and, largely, between the two ALSPAC mothers’ time points.
Finally, our analysis is restricted to women, so our conclusions
may not generalise to men.
Conclusions
In conclusion, sexual abuse was associated with DNA methyla-
tion age acceleration by approximately 3 years. We found no
evidence of associations of low SEP, a wide range of other types
of psychosocial adversity or a cumulative score of psychosocial
adversity in childhood with methylation age acceleration in
adulthood. Further large, well-characterised studies with
detailed measures of childhood adversity are needed to confirm
our findings. Changes to DNA methylation age, as a marker of
biological ageing, may potentially mediate associations
between sexual abuse and adverse outcomes.
Materials and Methods
Data
The Avon Longitudinal Study of Parents and Children (ALSPAC)
is a prospective, population-based birth cohort study that
recruited 14 541 pregnant women residents in Avon, UK, with
expected delivery dates between the 1 April 1991 and 31
December 1992 (38). The mothers, their partners and the index
child have been followed-up via clinics, questionnaires and
links to routine data. The mothers of this cohort form the par-
ticipants for this study. The ALSPAC mothers in this study were
mostly born in the early 1960s. The study website contains
details of all the data that are available through a fully search-
able data dictionary (http://www.bris.ac.uk/alspac/researchers/
data-access/data-dictionary/; date last accessed February 2,
2018). The Accessible Resource for Integrated Epigenomic
Studies (ARIES) project (39) includes 1018 mother-child pairs
from ALSPAC that had DNA methylation measured using the
Infinium HumanMethylation450BeadChip (Illumina, Inc).
Details of how to access the data for this cohort are described
elsewhere (39). Our analysis uses the mothers’ DNA methyla-
tion data, which were generated from peripheral blood samples
taken during pregnancy (mean age 29 years) and at a follow up
clinic 17 years later (mean age 47 years). Ethical approval was
obtained from the ALSPAC Ethics and Law Committee and the
Local Research Ethics Committees.
The MRC National Survey of Health and Development (NSHD)
is the UK’s oldest birth cohort (40). It is based on a nationally repre-
sentative sample of 5362 births out of all the single births that took
place within marriage in one week in March 1946 in England,
Scotland and Wales. DNA methylation was measured for a sub-
sample of 790 women in the cohort using the Infinium
HumanMethylation450BeadChip (Illumina, Inc) on buccal cell sam-
ples taken at age 53 years (41). All women gave written informed
consent for their samples to be used in genetic studies of health,
and the Central Manchester Ethics Committee approved the use of
these samples for epigenetic studies of health in 2012. Details of
how to access these data can be found online (http://www.nshd.
mrc.ac.uk/data.aspx; date last accessed February 2, 2018); data
requests should be submitted to mrclha.swiftinfo@ucl.ac.uk.
Psychosocial adversity during childhood
The following types of psychosocial adversity were assessed in
both ALSPAC and NSHD: maltreatment (neglect or abuse of any
kind), sub-optimal maternal bonding, childhood physical ill-
ness, parental mental illness, absence of the mother or father in
the household, parental physical illness or disability, parental
divorce or separation and death of mother or father in child-
hood (see Supplementary Material for further details). In
ALSPAC, women reported adverse childhood experiences retro-
spectively in questionnaires administered at the time of
Table 5. Association between cumulative psychosocial adversity score and methylation age acceleration adjusted for childhood SEP, stratified
by SEP in adulthood
Mean difference in epigenetic age acceleration (years) (95% CI) comparing categories of the cumulative psychosocial
adversity score
ALSPAC 29-year data ALSPAC 47-year data NSHD at 53 years
Low adult SEP (n ¼ 212) (n ¼ 197) (n ¼ 241)
0 (ref)
1 0.76 (2.39, 0.88) 0.65 (2.74, 1.43) 0.09 (1.56, 1.74)
2 0.51 (2.46, 1.43) 1.72 (0.75, 4.20) 0.75 (2.94, 1.45)
3 0.52 (2.49, 1.45) 0.72 (3.20, 1.77) 2.74 (6.24, 0.76)
High adult SEP (n¼ 432) (n¼ 411) (n¼ 397)
0 (ref)
1 0.08 (1.29, 1.13) 0.56 (0.63, 1.75) 1.20 (0.02, 2.39)
2 1.18 (2.68, 1.13) 0.26 (1.72, 1.20) 0.09 (1.77, 1.59)
3 0.19 (1.64, 1.27) 0.09 (1.32, 1.50) 0.50 (3.48, 2.48)
P for interaction 0.74 0.31 0.17
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enrolment into the study (mean age 28 years), through preg-
nancy and postnatally. In NSHD, adverse childhood experiences
were reported in interviews and questionnaires prospectively at
age 4 years (or at 7 or 11 years if missing), except for parental
bonding and maltreatment which were recalled when partici-
pants were age 43. The following additional measures were only
available in ALSPAC: adoption, time spent in local authority
care, and family functioning (i.e. the relationship between the
mother and father).
Socioeconomic position
Childhood SEP was assessed using father’s occupational social
class using the British Registrar General’s Social Classification,
and dichotomised as manual or non-manual. In ALSPAC this
was self-reported by the women on entry to the cohort; in
NSHD, it was reported by the mothers during health visitor
interviews at age 4 years (or at 7 or 11 years if missing). For adult
SEP, highest current occupational social class of the woman or
their partner was used (reported in late pregnancy in ALSPAC
and at age 53 years in NSHD). Adult SEP was dichotomised as
manual or non-manual in NSHD. Due to the low prevalence of
‘manual’ social class in the ALSPAC sample, adult SEP was
coded as ‘high’ (professional, managerial and technical occupa-
tions) or ‘low’ (skilled [non-manual and manual], semi-skilled
and unskilled occupations).
Epigenetic age
In ALSPAC, women had methylation measured during preg-
nancy (mean age 29 years) and/or at a follow up clinic 17 years
later (mean age 47 years). In NSHD, women had methylation
measured at age 53 years. Following extraction, DNA was bisul-
fite converted using the Zymo EZ DNA MethylationTM kit
(Zymo, Irvine, CA, USA). Infinium HumanMethylation450
BeadChips were used to measure genome-wide DNA methyla-
tion levels at over 485 000 CpG sites. The arrays were scanned
using an Illumina iScan, with initial quality review using
GenomeStudio. The level of methylation is expressed as a ‘beta’
value (b-value), ranging from 0 (no cytosine methylation) to 1
(complete cytosine methylation). b-Values are reported as per-
centages. Several quality control steps were included in the lab-
oratory pipeline, they are described in detail elsewhere (34).
Epigenetic age for each available measure was derived by apply-
ing Horvath’s epigenetic clock calculator (17) to raw b-values as
previously described (36). Epigenetic age acceleration was
defined as the residuals from a linear regression of epigenetic
age on chronological age, adjusted for blood cell heterogeneity
(ALSPAC only) by way of estimated cell-type proportions (42).
Statistical analysis
In both cohorts, we restricted analysis to females who had data
on at least one type of psychosocial adversity during childhood
and epigenetic age in adulthood. For ALSPAC, participants had
to have at least one of the two measures of epigenetic age,
although time points were then analysed separately. All out-
comes were analysed separately. Our a priori preferred analysis
strategy for assessing cumulative psychosocial adversity was to
create a data-driven weighted score using confirmatory factor
analysis (since theory-driven approaches to weighting are
highly subjective). However, this approach was not successful
in the NSHD cohort; model fit was poor and factor loadings for
all psychosocial adversity variables except for parental bonding
variables (lack of care and overprotection) were low. Details of
the model fit and factor loadings in the NSHD cohort are pro-
vided for information in the Supplementary Material. Thus, in
order to maximise power and enable comparability of estimates
from the two cohorts, we present results using a summary score
of the eight binary measures of psychosocial adversity meas-
ured in both cohorts. This is a common approach used in the
early life adversity literature (25), but has important limitations
(37) in that it makes the unrealistic assumption that all of the
separate types of psychosocial adversity have the same direc-
tion and magnitude of association with the outcome. That said,
the results from the factor analysis in ALSPAC were similar to
those using the summary score (full methods and results are
presented in Supplementary Material, Tables S1–S9). Linearity
of the association between the cumulative psychosocial adver-
sity score and epigenetic age acceleration was assessed with a
likelihood ratio test comparing models including the score as a
continuous or a categorical variable.
To increase power and minimise selection bias, multiple
imputation was used to impute data for participants who met
the inclusion criteria. The imputation equations included meas-
ures of adversity; chronological age; DNA methylation age and
age acceleration; childhood and adulthood SEP; fathers highest
qualification; mothers highest qualification (NSHD only). The
multivariate multiple imputation created 20 copies of the data
in which missing values were imputed, with an appropriate
level of randomness, by chained equations. The main analysis
results are obtained by averaging across the results from each
of these 20 datasets using Rubin’s rules (43). This procedure
appropriately modifies the standard errors for regression coeffi-
cients (used to calculate p-values and 95% confidence intervals)
to take account of uncertainty in both the imputations and the
estimate.
Multivariable linear regression models were used to assess
the associations of childhood SEP, each separate type of psycho-
social adversity, and the scores of cumulative psychosocial
adversity with epigenetic age acceleration in the following mod-
els: (i) unadjusted (ii) mutually adjusted for childhood SEP and
the cumulative psychosocial adversity score and (iii) addition-
ally adjusted for potential mediation by adult SEP. We also
assessed whether associations of childhood SEP and the cumu-
lative psychosocial adversity score with epigenetic age accelera-
tion differed according to adult SEP using likelihood ratio tests
for interaction tests. This was intended to test the hypothesis
that associations may only be present in people who are of low
SEP in adulthood, which has also been shown to have health
implications in later life (1,44,45). Sensitivity analyses were con-
ducted in which analyses were restricted to participants with
complete data on all variables, and using a second summary
score for cumulative psychosocial adversity in ALSPAC includ-
ing additional items only available in this cohort. Adversity
scores were coded as 0, 1, 2, 3þ.
Supplementary Material
Supplementary Material is available at HMG online.
Acknowledgements
We are extremely grateful to all the families who took part in
this study, the midwives for their help in recruiting them, and
the whole ALSPAC team, which includes interviewers, computer
6 | Human Molecular Genetics, 2018, Vol. 00, No. 00
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy036/4819279
by guest
on 13 February 2018
and laboratory technicians, clerical workers, research scientists,
volunteers, managers, receptionists and nurses.
We thank the study participants for their continuing partici-
pation in the MRC National Survey of Health and Development
(NSHD). We also thank members of the NSHD scientific and
data collection teams who have been involved in the NSHD data
collections.
Conflict of Interest statement. Tom Gaunt is conducting unrelated
research funded by GlaxoSmithKline PLC, Biogen MA Inc and
Sanofi. No other authors have conflicts of interest to declare.
The content is solely the responsibility of the authors and does
not necessarily represent the official views of the National
Institutes of Health.
Funding
UK Economic and Social Research Council [ES/M010317/1, ES/
N000382/1], National Institute on Aging of the National
Institutes of Health [Award No. R01AG048835], Career
Development Award fellowship from the UK Medical Research
Council [MR/M020894/1] to LDH. RBL, ELA, AJS, TRG, CLR and
LDH were funded from the University of Bristol and the UK
Medical Research Council [MC_UU_12013/2, MC_UU_12013/8,
MC_UU_12013/9]. The UK Medical Research Council and the
Wellcome Trust [Grant ref: 102215/2/13/2] and the University of
Bristol provide core support for ALSPAC. RBL is a PhD student
funded by the MRC Integrative Epidemiology Unit at the
University of Bristol. UK Medical Research Council provides core
funding for the MRC National Survey of Health and
Development and RH and DK [MC_UU_12019/1]. Part of this
research was undertaken at UCLH/UCL [MW and AET], which
received a proportion of its funding from the Department of
Health NIHR Biomedical Research Centres funding scheme.
Funding to pay the Open Access publication charges for this
article was provided by the MRC and ESRC.
References
1. Kaplan, G.A. and Keil, J.E. (1993) Socioeconomic factors and
cardiovascular disease: a review of the literature. Circulation,
88, 1973–1998.
2. Galobardes, B., Lynch, J.W. and Smith, G.D. (2004) Childhood
socioeconomic circumstances and cause-specific mortality
in adulthood: systematic review and interpretation.
Epidemiol. Rev., 26, 7–21.
3. Schooling, C.M., Jiang, CQiang., Lam, T.H., Zhang, WSen., Cheng,
K.K., Leung, G.M. and Uddin, M. (2011) Parental death during
childhood and adult cardiovascular risk in a developing coun-
try: the Guangzhou Biobank Cohort Study. PLoS One, 6, e19675.
4. Wu, C.S., Nohr, E.A., Bech, B.H., Vestergaard, M. and Olsen, J.
(2012) Long-term health outcomes in children born to moth-
ers with diabetes: a population-based cohort study. PLoS
One, 7, e36727.
5. Galobardes, B., Smith, G.D. and Lynch, J.W. (2006) Systematic
review of the influence of childhood socioeconomic circum-
stances on risk for cardiovascular disease in adulthood. Ann.
Epidemiol., 16, 91–104.
6. Norman, R.E., Byambaa, M., De, R., Butchart, A., Scott, J., Vos,
T. and Tomlinson, M. (2012) The long-term health consequen-
ces of child physical abuse, emotional abuse, and neglect: a
systematic review and meta-analysis. PLoSMed, 9, e1001349.
7. Relton, C.L. and Davey Smith, G. (2010) Epigenetic
Epidemiology of Common Complex Disease: prospects for
Prediction, Prevention, and Treatment. PLoS Med., 7,
e1000356.
8. Relton, C.L. and Smith, G.D. (2012) Is epidemiology ready for
epigenetics? Int. J. Epidemiol., 41, 5–9.
9. Provenc¸al, N., Suderman, M.J., Guillemin, C., Massart, R.,
Ruggiero, A., Wang, D., Bennett, A.J., Pierre, P.J., Friedman,
D.P. and Coˆte´, S.M. (2012) The signature of maternal rearing
in the methylome in rhesus macaque prefrontal cortex and
T cells. J. Neurosci., 32, 15626–15642.
10. Szyf, M. (2012) The early-life social environment and DNA
methylation. Clin. Genet., 81, 341–349.
11. Szyf, M. (2011) The early life social environment and DNA
methylation: dNA methylation mediating the long-term
impact of social environments early in life. Epigenetics, 6,
971–978.
12. McGowan, P.O., Suderman, M., Sasaki, A., Huang, T.C.T.,
Hallett, M., Meaney, M.J., Szyf, M. and Sirigu, A. (2011) Broad
epigenetic signature of maternal care in the brain of adult
rats. PLoS One, 6, e14739.
13. Borghol, N., Suderman, M., McArdle, W., Racine, A., Hallett,
M., Pembrey, M., Hertzman, C., Power, C. and Szyf, M. (2012)
Associations with early-life socio-economic position in
adult DNA methylation. Int. J. Epidemiol., 41, 62–74.
14. Suderman, M., McGowan, P.O., Sasaki, A., Huang, T.C.,
Hallett, M.T., Meaney, M.J., Turecki, G. and Szyf, M. (2012)
Conserved epigenetic sensitivity to early life experience in
the rat and human hippocampus. Proc. Natl. Acad. Sci. U. S. A,
109, 17266–17272.
15. Labonte´, B., Suderman, M., Maussion, G., Navaro, L., Yerko,
V., Mahar, I., Bureau, A., Mechawar, N., Szyf, M., Meaney, M.J.
and Turecki, G. (2012) Genome-wide epigenetic regulation
by early-life trauma. Arch. Gen. Psychiatry, 69, 722–731.
16. Vinkers, C.H., Kalafateli, A.L., Rutten, B.P., Kas, M.J.,
Kaminsky, Z., Turner, J.D. and Boks, M.P. (2015) Traumatic
stress and human DNA methylation: a critical review.
Epigenomics, 7, 593–608.
17. Horvath, S. (2013) DNA methylation age of human tissues
and cell types. Genome Biol., 14, 3156.
18. Tzanetakou, I.P., Katsilambros, N.L., Benetos, A., Mikhailidis,
D.P. and Perrea, D.N. (2012) “Is obesity linked to aging?”: adi-
pose tissue and the role of telomeres. Ageing Res. Rev., 11,
220–229.
19. Wang, Y. (2002) Is obesity associated with early sexual matu-
ration? A comparison of the association in American boys
versus girls. Pediatrics, 110, 903–910.
20. Dai, Y., Fu, J., Liang, L., Gong, C., Xiong, F., Luo, F., Liu, G. and
Chen, S. (2014) Association between obesity and sexual
maturation in Chinese children: a muticenter study. Int. J.
Obes., 38, 1312–1316.
21. Horvath, S., Erhart, W., Brosch, M., Ammerpohl, O.,
Scho¨nfels, W.v., Ahrens, M., Heits, N., Bell, J.T., Tsai, P.-C.
and Spector, T.D. (2014) Obesity accelerates epigenetic aging
of human liver. Proc. Natl. Acad. Sci. U. S. A, 111, 15538–15543.
22. Marioni, R.E., Shah, S., McRae, A.F., Ritchie, S.J., Muniz-
Terrera, G., Harris, S.E., Gibson, J., Redmond, P., Cox, S.R. and
Pattie, A. (2015) The epigenetic clock is correlated with phys-
ical and cognitive fitness in the Lothian Birth Cohort 1936.
Int. J. Epidemiol., 44, 1388–1396.
23. Marioni, R.E., Shah, S., McRae, A.F., Chen, B.H., Colicino, E.,
Harris, S.E., Gibson, J., Henders, A.K., Redmond, P. and Cox,
S.R. (2015) DNA methylation age of blood predicts all-cause
mortality in later life. Genome Biol., 16, 25.
24. Brown, D.W., Anda, R.F., Tiemeier, H., Felitti, V.J., Edwards,
V.J., Croft, J.B. and Giles, W.H. (2009) Adverse childhood
7Human Molecular Genetics, 2018, Vol. 00, No. 00 |
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy036/4819279
by guest
on 13 February 2018
experiences and the risk of premature mortality. Am. J. Prev.
Med., 37, 389–396.
25. Dong, M., Anda, R.F., Felitti, V.J., Dube, S.R., Williamson, D.F.,
Thompson, T.J., Loo, C.M. and Giles, W.H. (2004) The interre-
latedness of multiple forms of childhood abuse, neglect, and
household dysfunction. Child Abuse Negl., 28, 771–784.
26. Van Niel, C., Pachter, L.M., Wade, R., Jr, Felitti, V.J. and Stein,
M.T. (2014) Adverse events in children: predictors of adult
physical and mental conditions. J. Dev. Behav. Pediatr., 35,
549–551.
27. Vachon, D.D., Krueger, R.F., Rogosch, F.A. and Cicchetti, D.
(2015) Assessment of the harmful psychiatric and behavioral
effects of different forms of child maltreatment. JAMA
Psychiatry, 72, 1135–1142.
28. Gilbert, R., Widom, C.S., Browne, K., Fergusson, D., Webb, E.
and Janson, S. (2009) Burden and consequences of child mal-
treatment in high-income countries. Lancet, 373, 68–81.
29. Cecil, C.A., Smith, R.G., Walton, E., Mill, J., McCrory, E.J. and
Viding, E. (2016) Epigenetic signatures of childhood abuse
and neglect: implications for psychiatric vulnerability. J.
Psychiatr. Res., 83, 184–194.
30. Suderman, M., Borghol, N., Pappas, J.J., Pereira, S.M.P.,
Pembrey, M., Hertzman, C., Power, C. and Szyf, M. (2014)
Childhood abuse is associated with methylation of multiple
loci in adult DNA. BMCMed. Genomics, 7, 13.
31. Yang, B.-Z., Zhang, H., Ge, W., Weder, N., Douglas-
Palumberi, H., Perepletchikova, F., Gelernter, J. and
Kaufman, J. (2013) Child abuse and epigenetic mechanisms
of disease risk. Am. J. Prev. Med., 44, 101–107.
32. Cicchetti, D., Hetzel, S., Rogosch, F.A., Handley, E.D. and
Toth, S.L. (2016) An investigation of child maltreatment and
epigenetic mechanisms of mental and physical health risk.
Dev. Psychopathol., 28, 1305–1317.
33. Weder, N., Zhang, H., Jensen, K., Yang, B.Z., Simen, A.,
Jackowski, A., Lipschitz, D., Douglas-Palumberi, H., Ge, M.
and Perepletchikova, F. (2014) Child abuse, depression, and
methylation in genes involved with stress, neural plasticity,
and brain circuitry. J. Am. Acad. Child Adolesc. Psychiatry, 53,
417–424.
34. Simpkin, A.J., Suderman, M., Gaunt, T.R., Lyttleton, O.,
McArdle, W.L., Ring, S.M., Tilling, K., Smith, G.D. and Relton,
C.L. (2015) Longitudinal analysis of DNA methylation associ-
ated with birth weight and gestational age. Hum. Mol. Genet.,
24, 3752–3763.
35. Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G.,
Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B. and Gao, Y.
(2013) Genome-wide methylation profiles reveal quantita-
tive views of human aging rates. Mol. Cell, 49, 359–367.
36. Simpkin, A.J., Hemani, G., Suderman, M., Gaunt, T.R.,
Lyttleton, O., Mcardle, W.L., Ring, S.M., Sharp, G.C., Tilling, K.
and Horvath, S. (2015) Prenatal and early life influences on
epigenetic age in children: a study of mother–offspring pairs
from two cohort studies. Hum. Mol. Genet., 25, 191–201.
37. Howe, L.D., Tilling, K. and Lawlor, D.A. (2015) Studying the
life course health consequences of childhood adversity chal-
lenges and opportunities. Circulation, 131, 1645–1647.
38. Fraser, A., Macdonald-Wallis, C., Tilling, K., Boyd, A.,
Golding, J., Davey Smith, G., Henderson, J., Macleod, J.,
Molloy, L., Ness, A. et al. (2013) Cohort profile: the Avon
Longitudinal Study of Parents and Children: ALSPAC moth-
ers cohort. Int. J. Epidemiol., 42, 97–110.
39. Relton, C.L., Gaunt, T., McArdle, W., Ho, K., Duggirala, A.,
Shihab, H., Woodward, G., Lyttleton, O., Evans, D.M. and
Reik, W. (2015) Data resource profile: accessible resource for
integrated epigenomic studies (ARIES). Int. J. Epidemiol., 44,
1181–1190.
40. Kuh, D., Pierce, M., Adams, J., Deanfield, J., Ekelund, U.,
Friberg, P., Ghosh, A.K., Harwood, N., Hughes, A., Macfarlane,
P.W. et al. (2011) Cohort Profile: updating the cohort profile
for the MRC National Survey of Health and Development: a
new clinic-based data collection for ageing research. Int. J.
Epidemiol., 40, e1–e9.
41. Teschendorff, A.E., Yang, Z., Wong, A., Pipinikas, C.P., Jiao,
Y., Jones, A., Anjum, S., Hardy, R., Salvesen, H.B., Thirlwell,
C. et al. (2015) Correlation of smoking-associated DNA meth-
ylation changes in buccal cells with DNA methylation
changes in epithelial cancer. JAMA Oncol., 1, 476–485.
42. Houseman, E.A., Accomando, W.P., Koestler, D.C.,
Christensen, B.C., Marsit, C.J., Nelson, H.H., Wiencke, J.K. and
Kelsey, K.T. (2012) DNA methylation arrays as surrogate
measures of cell mixture distribution. BMC Bioinformatics,
13, 86.
43. Rubin, D.B. and Schenker, N. (1991) Multiple imputation in
health-are databases: an overview and some applications.
Stat. Med., 10, 585–598.
44. Smith, G.D., Neaton, J.D., Wentworth, D., Stamler, R. and
Stamler, J. (1996) Socioeconomic differentials in mortality
risk among men screened for the Multiple Risk Factor
Intervention Trial: i. White men. Am. J. Pub. Health, 86,
486–496.
45. Adler, N.E., Boyce, W.T., Chesney, M.A., Folkman, S. and
Syme, S.L. (1993) Socioeconomic inequalities in health: no
easy solution. JAMA, 269, 3140–3145.
8 | Human Molecular Genetics, 2018, Vol. 00, No. 00
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy036/4819279
by guest
on 13 February 2018
